• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular analysis of the abnormal expression of CD 154 in T cells as a mechanism of induction of autoinimune disease.

Research Project

Project/Area Number 14570431
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionTeikyo University School of Medicine

Principal Investigator

HIROHATA Shunsei  Teikyo University, Internal Medicine, Associate Professor, 医学部, 助教授 (90189895)

Co-Investigator(Kenkyū-buntansha) KIKUCHI Hirotoshi  Teikyo University, Internal Medicine, Assistant Professor, 医学部, 助手 (80338681)
MIYASHITA Taku  Teikyo University, Internal Medicine, Assistant Professor, 医学部, 助手 (00239401)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 2002: ¥1,900,000 (Direct Cost: ¥1,900,000)
KeywordsCD154 / T cell / mRNA / SLE / IFN-α / Jurkat / luciferase / IL-12 / stability / B細胞 / 固相化抗CD3抗体 / 抗CD28抗体
Research Abstract

Like IL-12, IFN-α has been found to play an important role in human Th1 responses. Whereas IL-12 enhances CD154 expression on human T cells, the effect of IFN-α has not been elucidated. The present study examined the effects of IFN-α on CD154 expression in human CD4+ T cells, with special attention to the relationship with Th1 responses. IFN-α suppressed CD154 protein and mRNA expression in CD4+ T cells at the initial phase of activation with immobilized anti-CD3, but thereafter enhanced it irrespective of the presence of IL-12. By contrast, IFN-α by itself did not enhance IFN-γ production or mRNA expression in CD4+ T cells in the absence of IL-12, whereas it enhanced it in the presence of IL-12. Either IFN-α or IL-12 did not influence the stability of CD154 mRNA in anti-CD3 activated CD4+ T cells. Rather luciferase assays using a reporter vector containing the CD154 promoter region demonstrate that both IFN-α and IL-12 upregulate the transcription of CD154 mRNA. These results indicate that IFN-α directly enhances CD154 expression in CD4+ T cells by up-regulating the transcription of CD154 mRNA independently of the induction of IFN-γ mRNA expression. The data also suggest that the optimal induction of human Th1 responses by IFN-α might require the presence of IL-12.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (21 results)

All Other

All Publications (21 results)

  • [Publications] Hirohata S, et al.: "Regulation of human B cell function by sulfasalazine and its metabolites."Int Immunopharm. 2. 631-640 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hirohata S, et al.: "Bone marrow CD34+ progenitor cells stimulated with stem cell factor and GM-CSF have the capacity to activate IgD- B cells through direct cellular interaction"J Leukoc Biol. 71. 987-995 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Shibuya H, et al.: "Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-α."Clin Exp Immunol. 132. 216-224 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hirohata S, Kikuchi H: "Behcet's disease."Arthritis Res Ther. 5. 139-146 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takizawa K, et al.: "Association of transporter associated with antigen processing genes with Behcet's disease in Japanese."Autoimmunity. 36. 161-165 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Iwaki-Egawa S, et al.: "High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen."J Rheumatol. 31. 17-22 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hirohata S, et al.: "Regulation of human B cell function by sulfasalazine and its metabolites"Int Immunopharm. 2. 631-640 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hirohata S, et al.: "Bone marrow CD34+ progenitor cells stimulated with stem cell factor and GM-CSF have the capacity to activate IgD-B cells through direct cellular interaction"J Leukoc Biol. 71. 987-995 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Shibuya H, et al.: "Differential regulation of Th1 responses and CD 154 expression in human CD4+ T cells by IFN-α"Clin Exp Immunol. 132. 216-224 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hirohata S, Kikuchi H: "Behcet's disease"Arthritis Res Ther. 5. 139-146 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takizawa K, et al.: "Association of transporter associated with antigen processing genes with Behcet's disease in Japanese"Autoimmunity. 36. 161-165 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Iwaki-Egawa S, et al.: "High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen"J Rheumatol. 31. 17-22 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Shibuya H, et al.: "Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-α."Clin Exp Immunol. 132. 216-224 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hirohata S, Kikuchi H: "Behcet's disease."Arthritis Res Ther. 5. 139-146 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takizawa K, et al.: "Association of transporter associated with antigen processing genes with Behcet's disease in Japanese."Autoimmunity. 36. 161-165 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Iwai M, et al.: "Autoimmune hepatitis in a patient with systemic lupus erythematosus."Clin Rheumatol. 22. 234-236 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takayanagi M, et al.: "Myocardial infarction caused by rheumatoid vasculitis : histological evidence of the involvement of T lymphocytes."Rheumatol Int. 23. 315-318 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Iwaki-Egawa S, et al.: "High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthrit is detected by ELISA using human erythrocyte calpastatin as antigen."J Rheumatol. 31. 17-22 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hirohata S, et al.: "Regulation of human B cell function by sulfasalazine and its metabolites"Int Immunopharm. 2. 631-640 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hirohata S, et al.: "Bone marrow CD34+ progenitor cells stimulated with stem cell factor and GM-CSF have the capacity to activate IgD-B cells through direct cellular interaction"J Leukoc Biol. 71. 987-995 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Matsuda T, et al.: "Efficacy of Rebamipide as Adjunctive Therapy in the Treatment of Recurrent Oral Aphthous Ulcers in Patients with Behcet's Disease : A Randomised, Double-Blind, Placebo-Sontrolled Study"Drugs R D. 4. 19-28 (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi